Self-Assembly of Short Peptides Activates Specific ER-Phagy and Induces Pyroptosis for Enhanced Tumor Immunotherapy

Yunhua Zhang1, Chengyuan Qian2, Chengyan Chu2

  • 1State Key Laboratory of Coordination Chemistry, School of Chemistry and Chemical Engineering, Chemistry and Biomedicine Innovation Center (ChemBIC), ChemBioMed Interdisciplinary Research Center, Nanjing University, Nanjing, Jiangsu, 210023, P.R. China.

Insights

Researchers developed specific short peptides (D-FFxFFs) to induce endoplasmic reticulum-autophagy (ER-phagy). This targeted approach activates pyroptosis and an antitumor immune response, offering a novel cancer immunotherapy strategy.

Area of Science:

  • Cellular Biology
  • Molecular Mechanisms
  • Immunology

Background:

  • Developing specific endoplasmic reticulum-autophagy (ER-phagy) inducers is crucial for understanding ER-phagy mechanisms and cancer immunotherapy.
  • Current methods often lead to nonselective autophagy, affecting other organelles.

Purpose of the Study:

  • To design and synthesize novel, specific ER-phagy inducers.
  • To investigate their potential in cancer immunotherapy by triggering pyroptosis and immune responses.

Main Methods:

  • Design and synthesis of simple, stable short peptides (D-FFxFFs).
  • Assessment of peptide localization and self-assembly in the endoplasmic reticulum (ER).
  • Analysis of ER-phagy receptor upregulation, unfolded protein response (UPR) activation, and pyroptosis induction.

Main Results:

  • D-FFxFFs specifically induce ER-phagy without affecting other organelles.
  • Peptides activate UPR via IRE1-JNK and PERK-ATF4 pathways.
  • ER-phagy triggers ER calcium release, leading to GSDMD-mediated pyroptosis and a distinct antitumor immune response.

Conclusions:

  • D-FFxFFs serve as effective tools for studying ER-phagy mechanisms.
  • This peptide-based strategy offers a promising approach for cancer immunotherapy, inducing pyroptosis and antitumor immunity without acquired drug resistance.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
457
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
6.1K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
5.8K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized...
3.3K